| A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes R Candido, JM Forbes, MC Thomas, V Thallas, RG Dean, WC Burns, ... Circulation research 92 (7), 785-792, 2003 | 637 | 2003 |
| Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) MD Oldfield, LA Bach, JM Forbes, D Nikolic-Paterson, A McRobert, ... The Journal of clinical investigation 108 (12), 1853-1863, 2001 | 613 | 2001 |
| RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes MT Coughlan, DR Thorburn, SA Penfold, A Laskowski, BE Harcourt, ... Journal of the American Society of Nephrology 20 (4), 742-752, 2009 | 510 | 2009 |
| Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis JM Forbes, LTL Yee, V Thallas, M Lassila, R Candido, ... Diabetes 53 (7), 1813-1823, 2004 | 426 | 2004 |
| Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy JM Forbes, ME Cooper, V Thallas, WC Burns, MC Thomas, GC Brammar, ... Diabetes 51 (11), 3274-3282, 2002 | 403 | 2002 |
| Inhibition of NADPH oxidase prevents advanced glycation end product–mediated damage in diabetic nephropathy through a protein kinase C-α–dependent pathway V Thallas-Bonke, SR Thorpe, MT Coughlan, K Fukami, FYT Yap, ... Diabetes 57 (2), 460-469, 2008 | 399 | 2008 |
| Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy JC Jha, SP Gray, D Barit, J Okabe, A El-Osta, T Namikoshi, ... Journal of the American Society of Nephrology 25 (6), 1237-1254, 2014 | 368 | 2014 |
| The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes JM Forbes, V Thallas, MC Thomas, HW Founds, WC Burns, G Jerums, ... The FASEB Journal 17 (12), 1762-1764, 2003 | 350 | 2003 |
| Connective tissue growth factor plays an important role in advanced glycation end product–induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal … WC Burns, SM Twigg, JM Forbes, J Pete, C Tikellis, V Thallas-Bonke, ... Journal of the American Society of Nephrology 17 (9), 2484-2494, 2006 | 341 | 2006 |
| Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy JM Forbes, SR Thorpe, V Thallas-Bonke, J Pete, MC Thomas, ER Deemer, ... Journal of the American Society of Nephrology 16 (8), 2363-2372, 2005 | 288 | 2005 |
| Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury T Soulis, V Thallas, S Youssef, RE Gilbert, BG McWilliam, ... Diabetologia 40, 619-628, 1997 | 270 | 1997 |
| Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E–deficient mice P Lewis, N Stefanovic, J Pete, AC Calkin, S Giunti, V Thallas-Bonke, ... Circulation 115 (16), 2178-2187, 2007 | 267 | 2007 |
| Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis R Candido, TJ Allen, M Lassila, Z Cao, V Thallas, ME Cooper, ... Circulation 109 (12), 1536-1542, 2004 | 266 | 2004 |
| Renoprotective effects of a novel inhibitor of advanced glycation JM Forbes, T Soulis, V Thallas, S Panagiotopoulos, DM Long, S Vasan, ... Diabetologia 44, 108-114, 2001 | 216 | 2001 |
| Advanced glycation end products are direct modulators of β-cell function MT Coughlan, FYT Yap, DCK Tong, S Andrikopoulos, A Gasser, ... Diabetes 60 (10), 2523-2532, 2011 | 187 | 2011 |
| Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α− dependent … V Thallas-Bonke, C Lindschau, B Rizkalla, LA Bach, G Boner, M Meier, ... Diabetes 53 (11), 2921-2930, 2004 | 185 | 2004 |
| ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2) 27 rat JL Wilkinson-Berka, DJ Kelly, SM Koerner, K Jaworski, B Davis, V Thallas, ... Diabetes 51 (11), 3283-3289, 2002 | 179 | 2002 |
| Imatinib attenuates diabetes-associated atherosclerosis M Lassila, TJ Allen, Z Cao, V Thallas, KA Jandeleit-Dahm, R Candido, ... Arteriosclerosis, thrombosis, and vascular biology 24 (5), 935-942, 2004 | 178 | 2004 |
| The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation ME Cooper, V Thallas, J Forbes, E Scalbert, S Sastra, I Darby, T Soulis Diabetologia 43, 660-664, 2000 | 169 | 2000 |
| Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products M Lassila, KK Seah, TJ Allen, V Thallas, MC Thomas, R Candido, ... Journal of the American Society of Nephrology 15 (8), 2125-2138, 2004 | 161 | 2004 |
